Sotera Health Co Financials

SHC

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Sotera Health Co (SHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

100

Sotera Health Co has an operating margin of 27.1%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 26.4% the prior year.

Growth

Sotera Health Co's revenue grew a modest 4.9% year-over-year to $1.1B. This slow but positive growth earns a score of 43/100.

Leverage

Sotera Health Co has elevated debt relative to equity (D/E of 5.45), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.75, Sotera Health Co holds $2.75 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 90/100.

Cash Flow

Sotera Health Co's free cash flow margin of 4.1% results in a low score of 21/100. Capital expenditures of $179.1M absorb a large share of operating cash flow.

Returns

Sotera Health Co's ROE of 11.0% shows moderate profitability relative to equity, earning a score of 44/100. This is down from 11.6% the prior year.

Altman Z-Score Distress

1.64

Sotera Health Co scores 1.64, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.9B) relative to total liabilities ($2.7B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

5/9

Sotera Health Co passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

5.05x

For every $1 of reported earnings, Sotera Health Co generates $5.05 in operating cash flow ($224.2M OCF vs $44.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Revenue

$1.1B

YoY+4.9%

5Y CAGR+7.2%

Sotera Health Co generated $1.1B in revenue in fiscal year 2024. This represents an increase of 4.9% from the prior year.

EBITDA

$381.9M

YoY+8.1%

5Y CAGR+8.8%

Sotera Health Co's EBITDA was $381.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.1% from the prior year.

Free Cash Flow

$45.1M

YoY+112.4%

5Y CAGR-13.2%

Sotera Health Co generated $45.1M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 112.4% from the prior year.

Net Income

$44.4M

YoY-13.6%

Sotera Health Co reported $44.4M in net income in fiscal year 2024. This represents a decrease of 13.6% from the prior year.

EPS (Diluted)

$0.16

YoY-11.1%

Sotera Health Co earned $0.16 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 11.1% from the prior year.

Cash & Debt

$277.2M

YoY-6.5%

5Y CAGR+34.5%

Sotera Health Co held $277.2M in cash against $2.2B in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

N/A

Gross Margin

54.7%

YoY-0.3pp

5Y CAGR+3.9pp

Sotera Health Co's gross margin was 54.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin

27.1%

YoY+0.7pp

5Y CAGR+3.5pp

Sotera Health Co's operating margin was 27.1% in fiscal year 2024, reflecting core business profitability. This is up 0.7 percentage points from the prior year.

Net Margin

4.0%

YoY-0.9pp

5Y CAGR+6.7pp

Sotera Health Co's net profit margin was 4.0% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.9 percentage points from the prior year.

Return on Equity

11.0%

YoY-0.6pp

Sotera Health Co's ROE was 11.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$179.1M

YoY-16.7%

5Y CAGR+25.6%

Sotera Health Co invested $179.1M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 16.7% from the prior year.

SHC Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$1.1B+4.9%	$1.0B+4.5%	$1.0B+7.8%	$931.5M+13.9%	$818.2M+5.1%	$778.3M
Cost of Revenue	$498.1M+5.5%	$472.1M+5.7%	$446.7M+8.2%	$412.8M+10.2%	$374.6M-2.2%	$382.9M
Gross Profit	$602.3M+4.4%	$577.2M+3.6%	$557.0M+7.4%	$518.7M+16.9%	$443.6M+12.2%	$395.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$242.6M+2.5%	$236.7M-3.7%	$245.7M+24.0%	$198.2M+11.0%	$178.5M+21.1%	$147.5M
Operating Income	$297.6M+7.6%	$276.7M+11.4%	$248.3M-3.3%	$256.7M+24.6%	$206.0M+12.2%	$183.6M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$69.5M+27.1%	$54.7M+672.8%	-$9.5M-116.3%	$58.6M+4380.1%	-$1.4M-107.0%	$19.5M
Net Income	$44.4M-13.6%	$51.4M+122.0%	-$233.6M-299.8%	$116.9M+402.7%	-$38.6M-85.2%	-$20.9M
EPS (Diluted)	$0.16-11.1%	$0.18+121.7%	$-0.83-302.4%	$0.41+356.2%	$-0.16-77.8%	$-0.09

Metric	Q3'25	Q2'25	Q1'25	Q4'23	Q3'24	Q2'24	Q1'24	Q4'22
Revenue	$311.3M+5.8%	$294.3M+15.6%	$254.5M-18.0%	$310.2M+17.9%	$263.2M+3.1%	$255.3M+15.7%	$220.6M-12.3%	$251.6M
Cost of Revenue	$133.8M+4.7%	$127.7M+7.2%	$119.1M-8.5%	$130.2M+11.1%	$117.2M+1.3%	$115.7M+6.1%	$109.1M-0.7%	$109.9M
Gross Profit	$177.6M+6.6%	$166.6M+23.0%	$135.4M-24.8%	$180.1M+23.4%	$146.0M+4.6%	$139.6M+25.2%	$111.5M-21.3%	$141.7M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$63.3M-8.1%	$68.9M+9.2%	$63.1M+4.5%	$60.4M+11.5%	$54.1M-10.2%	$60.3M-2.6%	$61.9M-6.1%	$65.9M
Operating Income	$87.1M+13.5%	$76.8M+44.4%	$53.2M-48.9%	$104.0M+36.7%	$76.1M+20.4%	$63.2M+89.4%	$33.4M-44.5%	$60.2M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$24.5M+124.4%	$10.9M+799.6%	-$1.6M-105.8%	$27.0M+91.0%	$14.1M+28.8%	$11.0M+328.6%	$2.6M+104.4%	-$58.8M
Net Income	$48.4M+507.9%	$8.0M+160.0%	-$13.3M-134.3%	$38.7M+383.2%	-$13.7M-158.1%	$23.5M+727.3%	$2.8M+100.9%	-$319.7M
EPS (Diluted)	$0.17+466.7%	$0.03+160.0%	$-0.05-135.7%	$0.14+380.0%	$-0.05-162.5%	$0.08+700.0%	$0.01+100.9%	$-1.14

SHC Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$3.1B-1.9%	$3.1B+0.4%	$3.1B+11.8%	$2.8B+1.0%	$2.8B	N/A
Current Assets	$526.0M-5.6%	$557.2M-13.6%	$645.0M+86.4%	$346.0M+9.8%	$315.0M	N/A
Cash & Equivalents	$277.2M-6.5%	$296.4M-25.0%	$395.2M+269.6%	$106.9M+4.4%	$102.4M+62.5%	$63.0M
Inventory	$49.2M+1.7%	$48.3M+30.1%	$37.1M-31.6%	$54.3M+59.2%	$34.1M	N/A
Accounts Receivable	$140.3M-5.0%	$147.7M+24.7%	$118.5M+9.5%	$108.2M+17.9%	$91.7M	N/A
Goodwill	$1.1B-2.7%	$1.1B+0.9%	$1.1B-1.7%	$1.1B+0.4%	$1.1B+7.7%	$1.0B
Total Liabilities	$2.7B-0.7%	$2.7B-2.9%	$2.8B+25.6%	$2.2B-4.5%	$2.3B	N/A
Current Liabilities	$191.0M-17.2%	$230.7M-70.9%	$791.6M+391.2%	$161.2M+14.6%	$140.6M	N/A
Long-Term Debt	$2.2B-0.7%	$2.2B+27.3%	$1.7B+0.2%	$1.7B-4.5%	$1.8B	N/A
Total Equity	$404.9M-8.7%	$443.7M+26.7%	$350.2M-40.2%	$586.1M+29.6%	$452.3M+170.5%	-$641.1M
Retained Earnings	-$610.0M+6.8%	-$654.4M+7.3%	-$705.8M-49.5%	-$472.2M+19.8%	-$589.1M	N/A

Metric	Q3'25	Q2'25	Q1'25	Q4'23	Q3'24	Q2'24	Q1'24	Q4'22
Total Assets	$3.2B-1.0%	$3.2B+3.8%	$3.1B-1.1%	$3.1B+3.1%	$3.0B-1.2%	$3.1B-9.9%	$3.4B+9.5%	$3.1B
Current Assets	$577.8M-5.0%	$608.2M+9.6%	$555.0M-0.4%	$557.2M+7.2%	$519.6M-4.9%	$546.7M-40.8%	$923.8M+43.2%	$645.0M
Cash & Equivalents	$299.2M-10.0%	$332.4M+9.2%	$304.4M+2.7%	$296.4M+21.0%	$245.0M-6.8%	$262.7M-59.5%	$647.9M+63.9%	$395.2M
Inventory	$49.9M-16.8%	$59.9M-1.8%	$61.0M+26.3%	$48.3M+27.4%	$37.9M-9.9%	$42.1M-9.9%	$46.7M+25.8%	$37.1M
Accounts Receivable	$142.4M+4.3%	$136.6M+6.6%	$128.1M-13.3%	$147.7M+24.7%	$118.4M+0.9%	$117.3M+7.5%	$109.2M-7.9%	$118.5M
Goodwill	$1.1B-0.5%	$1.1B+1.9%	$1.1B-2.4%	$1.1B+0.9%	$1.1B-0.9%	$1.1B+0.6%	$1.1B+0.1%	$1.1B
Total Liabilities	$2.6B-2.6%	$2.7B+0.8%	$2.7B-0.1%	$2.7B+1.0%	$2.7B+0.1%	$2.7B-13.0%	$3.1B+10.3%	$2.8B
Current Liabilities	$242.4M-1.6%	$246.3M+9.0%	$226.0M-2.0%	$230.7M+15.0%	$200.6M+0.1%	$200.3M-66.6%	$600.1M-24.2%	$791.6M
Long-Term Debt	$2.1B-3.3%	$2.2B-0.1%	$2.2B-0.8%	$2.2B0.0%	$2.2B0.0%	$2.2B0.0%	$2.2B+27.2%	$1.7B
Total Equity	$550.5M+7.7%	$511.3M+23.5%	$414.1M-6.7%	$443.7M+17.6%	$377.5M-9.8%	$418.4M+15.9%	$361.1M+3.1%	$350.2M
Retained Earnings	-$566.9M+7.9%	-$615.3M+1.3%	-$623.3M+4.8%	-$654.4M+5.6%	-$693.1M-2.0%	-$679.5M+3.3%	-$703.0M+0.4%	-$705.8M

SHC Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$224.2M+251.7%	-$147.7M-153.1%	$278.0M-1.3%	$281.5M+133.5%	$120.6M-19.1%	$149.0M
Capital Expenditures	$179.1M-16.7%	$215.0M+17.9%	$182.4M+78.5%	$102.2M+90.9%	$53.5M-6.5%	$57.3M
Free Cash Flow	$45.1M+112.4%	-$362.7M-479.5%	$95.6M-46.7%	$179.4M+167.4%	$67.1M-26.9%	$91.8M
Investing Cash Flow	-$179.0M+16.7%	-$214.9M-18.1%	-$181.9M-13.8%	-$159.8M-0.7%	-$158.7M-177.2%	-$57.3M
Financing Cash Flow	-$50.6M-119.0%	$266.0M+34.5%	$197.8M+268.6%	-$117.3M-259.7%	$73.4M+158.3%	-$126.0M
Dividends Paid	N/A	N/A	N/A	$0	$0-100.0%	$691.2M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$34.0M	$0

Metric	Q3'25	Q2'25	Q1'25	Q4'23	Q3'24	Q2'24	Q1'24	Q4'22
Operating Cash Flow	$71.2M+23.9%	$57.4M+3.4%	$55.5M-50.9%	$113.1M+170.3%	$41.8M+112.4%	-$336.6M-1093.7%	$33.9M-66.8%	$101.9M
Capital Expenditures	$36.2M+15.8%	$31.2M+56.8%	$19.9M-69.3%	$64.8M+24.6%	$52.0M-2.1%	$53.1M+18.1%	$45.0M-37.3%	$71.7M
Free Cash Flow	$35.0M+33.6%	$26.2M-26.4%	$35.6M-26.3%	$48.3M+575.1%	-$10.2M+97.4%	-$389.7M-3401.7%	-$11.1M-136.9%	$30.2M
Investing Cash Flow	-$33.3M-6.7%	-$31.2M-57.1%	-$19.9M+69.3%	-$64.8M-24.7%	-$52.0M+2.2%	-$53.1M-18.2%	-$45.0M+37.3%	-$71.7M
Financing Cash Flow	-$77.3M-1015.5%	-$6.9M+14.3%	-$8.1M-113.2%	-$3.8M-9.8%	-$3.5M-386.5%	-$710K-100.3%	$273.9M+37.5%	$199.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SHC Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	54.7%-0.3pp	55.0%-0.5pp	55.5%-0.2pp	55.7%+1.5pp	54.2%+3.4pp	50.8%
Operating Margin	27.1%+0.7pp	26.4%+1.6pp	24.7%-2.8pp	27.6%+2.4pp	25.2%+1.6pp	23.6%
Net Margin	4.0%-0.9pp	4.9%+28.2pp	-23.3%-35.8pp	12.6%+17.3pp	-4.7%-2.0pp	-2.7%
Return on Equity	11.0%-0.6pp	11.6%	N/A	19.9%	N/A	N/A
Return on Assets	1.5%-0.2pp	1.6%+9.1pp	-7.5%-11.7pp	4.2%+5.6pp	-1.4%	N/A
Current Ratio	2.75+0.3	2.42+1.6	0.81-1.3	2.15-0.1	2.24	N/A
Debt-to-Equity	5.45+0.4	5.01+0.0	4.99+2.0	2.97-1.1	4.03	N/A
FCF Margin	4.1%+38.7pp	-34.6%-44.1pp	9.5%-9.7pp	19.3%+11.1pp	8.2%-3.6pp	11.8%

Metric	Q3'25	Q2'25	Q1'25	Q4'23	Q3'24	Q2'24	Q1'24	Q4'22
Gross Margin	57.0%+0.4pp	56.6%+3.4pp	53.2%-4.8pp	58.1%+2.6pp	55.5%+0.8pp	54.7%+4.1pp	50.5%-5.8pp	56.3%
Operating Margin	30.0%+2.3pp	27.8%+6.3pp	21.4%-12.1pp	33.5%+4.6pp	28.9%+4.2pp	24.8%+9.6pp	15.1%-8.8pp	23.9%
Net Margin	15.6%+12.8pp	2.7%+7.9pp	-5.2%-17.7pp	12.5%+17.7pp	-5.2%-14.4pp	9.2%+7.9pp	1.3%+128.4pp	-127.1%
Return on Equity	8.8%+7.2pp	1.6%+0.1pp	1.5%-7.2pp	8.7%	N/A	5.6%+4.8pp	0.8%	N/A
Return on Assets	1.5%+1.3pp	0.3%+0.7pp	-0.4%-1.7pp	1.2%+1.7pp	-0.4%-1.2pp	0.8%+0.7pp	0.1%+10.3pp	-10.3%
Current Ratio	2.38-0.1	2.47+0.0	2.46+0.0	2.42-0.2	2.59-0.1	2.73+1.2	1.54+0.7	0.81
Debt-to-Equity	3.87-0.4	4.31-1.0	5.33+0.3	5.01-0.9	5.89+0.6	5.31-0.8	6.15+1.2	4.99
FCF Margin	11.2%+2.3pp	8.9%-5.1pp	14.0%-1.6pp	15.6%+19.4pp	-3.9%+148.8pp	-152.7%-147.6pp	-5.1%-17.0pp	12.0%

Similar Companies

Radnet RDNT

$5.5B

GeneDx Holdings Corp WGS

$2.6B

Charles Riv Labs Intl Inc CRL

$8.1B

Guardant Health GH

$13.8B

Revvity Inc RVTY

$11.3B

Frequently Asked Questions

What is Sotera Health Co's annual revenue?

Sotera Health Co (SHC) reported $1.1B in total revenue for fiscal year 2024. This represents a 4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sotera Health Co's revenue growing?

Sotera Health Co (SHC) revenue grew by 4.9% year-over-year, from $1.0B to $1.1B in fiscal year 2024.

Is Sotera Health Co profitable?

Yes, Sotera Health Co (SHC) reported a net income of $44.4M in fiscal year 2024, with a net profit margin of 4.0%.

What is Sotera Health Co's earnings per share (EPS)?

Sotera Health Co (SHC) reported diluted earnings per share of $0.16 for fiscal year 2024. This represents a -11.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Sotera Health Co's EBITDA?

Sotera Health Co (SHC) had EBITDA of $381.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Sotera Health Co have?

As of fiscal year 2024, Sotera Health Co (SHC) had $277.2M in cash and equivalents against $2.2B in long-term debt.

What is Sotera Health Co's gross margin?

Sotera Health Co (SHC) had a gross margin of 54.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sotera Health Co's operating margin?

Sotera Health Co (SHC) had an operating margin of 27.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Sotera Health Co's net profit margin?

Sotera Health Co (SHC) had a net profit margin of 4.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Sotera Health Co's return on equity (ROE)?

Sotera Health Co (SHC) has a return on equity of 11.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Sotera Health Co's free cash flow?

Sotera Health Co (SHC) generated $45.1M in free cash flow during fiscal year 2024. This represents a 112.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sotera Health Co's operating cash flow?

Sotera Health Co (SHC) generated $224.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Sotera Health Co's total assets?

Sotera Health Co (SHC) had $3.1B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Sotera Health Co's capital expenditures?

Sotera Health Co (SHC) invested $179.1M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

What is Sotera Health Co's current ratio?

Sotera Health Co (SHC) had a current ratio of 2.75 as of fiscal year 2024, which is generally considered healthy.

What is Sotera Health Co's debt-to-equity ratio?

Sotera Health Co (SHC) had a debt-to-equity ratio of 5.45 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Sotera Health Co's return on assets (ROA)?

Sotera Health Co (SHC) had a return on assets of 1.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Sotera Health Co's Altman Z-Score?

Sotera Health Co (SHC) has an Altman Z-Score of 1.64, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Sotera Health Co's Piotroski F-Score?

Sotera Health Co (SHC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sotera Health Co's earnings high quality?

Sotera Health Co (SHC) has an earnings quality ratio of 5.05x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Sotera Health Co?

Sotera Health Co (SHC) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.